Chemed Co. (NYSE:CHE) Shares Bought by Sugarloaf Wealth Management LLC

Sugarloaf Wealth Management LLC increased its position in Chemed Co. (NYSE:CHE - Free Report) by 21.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,150 shares of the company's stock after buying an additional 1,285 shares during the period. Chemed accounts for 0.7% of Sugarloaf Wealth Management LLC's portfolio, making the stock its 27th largest holding. Sugarloaf Wealth Management LLC's holdings in Chemed were worth $3,788,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Thrivent Financial for Lutherans increased its holdings in shares of Chemed by 300.3% in the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company's stock valued at $63,249,000 after purchasing an additional 87,449 shares in the last quarter. International Assets Investment Management LLC bought a new position in shares of Chemed during the third quarter worth about $437,150,000. FMR LLC lifted its position in Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after buying an additional 45,917 shares in the last quarter. Epoch Investment Partners Inc. grew its stake in shares of Chemed by 22.1% in the second quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company's stock valued at $121,068,000 after buying an additional 40,358 shares in the last quarter. Finally, Bridges Investment Management Inc. increased its position in Chemed by 110.7% during the second quarter. Bridges Investment Management Inc. now owns 70,080 shares of the company's stock worth $38,024,000 after buying an additional 36,813 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Price Performance

Shares of CHE stock traded down $9.42 on Friday, hitting $522.60. The stock had a trading volume of 104,928 shares, compared to its average volume of 79,671. The stock has a market cap of $7.87 billion, a price-to-earnings ratio of 26.41, a price-to-earnings-growth ratio of 2.32 and a beta of 0.47. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The business has a 50 day moving average of $545.51 and a 200 day moving average of $562.53.

Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. During the same quarter in the previous year, the firm earned $5.32 earnings per share. The company's revenue for the quarter was up 7.4% compared to the same quarter last year. As a group, research analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.38%. Chemed's dividend payout ratio (DPR) is presently 10.11%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on CHE shares. Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th.

Insider Activity at Chemed

In other news, EVP Spencer S. Lee sold 732 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares in the company, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.